| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 263.20M | 252.95M | 237.65M | 246.34M | 273.60M | 275.99M |
| Gross Profit | 130.16M | 128.78M | 119.72M | 92.52M | 99.03M | 108.10M |
| EBITDA | 6.28M | 14.25M | 31.50M | 15.19M | 25.01M | 26.93M |
| Net Income | 2.58M | 6.55M | 13.63M | -19.32M | -9.08M | -4.04M |
Balance Sheet | ||||||
| Total Assets | 207.23M | 235.43M | 230.33M | 244.23M | 295.58M | 264.57M |
| Cash, Cash Equivalents and Short-Term Investments | 94.89M | 120.32M | 88.27M | 74.40M | 63.27M | 122.34M |
| Total Debt | 10.80M | 15.89M | 25.10M | 33.28M | 53.45M | 11.48M |
| Total Liabilities | 63.90M | 89.97M | 90.83M | 118.21M | 149.72M | 109.84M |
| Stockholders Equity | 143.33M | 145.47M | 139.50M | 126.02M | 145.85M | 154.73M |
Cash Flow | ||||||
| Free Cash Flow | 14.60M | 12.19M | 1.78M | 22.15M | -65.00K | 34.92M |
| Operating Cash Flow | 19.19M | 31.15M | 4.05M | 24.11M | 1.60M | 37.89M |
| Investing Cash Flow | 25.39M | 11.67M | 19.35M | -177.00K | -50.52M | -1.18M |
| Financing Cash Flow | -5.41M | -10.16M | -9.07M | -11.28M | -11.44M | -16.81M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | HK$349.70M | 10.28 | 3.77% | 10.32% | -6.67% | -29.55% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | HK$631.85M | 20.32 | 3.92% | ― | -0.92% | -71.88% | |
56 Neutral | HK$113.85M | 41.11 | 1.83% | ― | 5.99% | -74.29% | |
49 Neutral | HK$305.70M | -7.63 | -23.55% | ― | 10.42% | 11.14% | |
45 Neutral | HK$100.00M | 15.15 | 2.37% | ― | -1.65% | 230.00% | |
41 Neutral | HK$981.03M | -15.76 | -12.38% | ― | 39.29% | -71.82% |
BaWang International (Group) Holding Limited has announced the establishment of a Remuneration Committee as part of its corporate governance framework. This committee, consisting of at least three directors with a majority being independent non-executive directors, will oversee remuneration policies and practices, ensuring transparency and alignment with shareholder interests. This move is expected to enhance the company’s governance structure and potentially improve investor confidence.
The most recent analyst rating on (HK:1338) stock is a Hold with a HK$0.04 price target. To see the full list of analyst forecasts on BaWang International (Group) Holding Limited stock, see the HK:1338 Stock Forecast page.
BaWang International (Group) Holding Limited has announced the establishment of a Nomination Committee by its Board of Directors. This committee will consist of at least three members, primarily independent non-executive directors, and aims to enhance corporate governance by overseeing the nomination process for board appointments. The creation of this committee is expected to strengthen the company’s governance structure and ensure diversity and transparency in its board appointments, potentially impacting its market positioning and stakeholder confidence.
The most recent analyst rating on (HK:1338) stock is a Hold with a HK$0.04 price target. To see the full list of analyst forecasts on BaWang International (Group) Holding Limited stock, see the HK:1338 Stock Forecast page.
BaWang International (Group) Holding Limited has announced the establishment of an Audit and Risk Management Committee to enhance its corporate governance structure. The committee will consist of non-executive directors, with a majority being independent, to ensure transparency and accountability in financial oversight. This move is expected to strengthen the company’s compliance with the Hong Kong Stock Exchange’s listing rules and improve investor confidence.
The most recent analyst rating on (HK:1338) stock is a Hold with a HK$0.04 price target. To see the full list of analyst forecasts on BaWang International (Group) Holding Limited stock, see the HK:1338 Stock Forecast page.